Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.40727 | 16 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.38632 | 16 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.3951 | 16 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.34702 | 16 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.36565 | 17 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.42685 | 15 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.50815 | 20 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.36952 | 16 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.36486 | 16 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.38248 | 16 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.37979 | 16 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.36763 | 16 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.3828 | 16 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.38352 | 16 |